Hybrigenics A Stock Net Asset

3HB Stock  EUR 0.01  0.0002  2.82%   
HYBRIGENICS A fundamentals help investors to digest information that contributes to HYBRIGENICS's financial success or failures. It also enables traders to predict the movement of HYBRIGENICS Stock. The fundamental analysis module provides a way to measure HYBRIGENICS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to HYBRIGENICS stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

HYBRIGENICS A Company Net Asset Analysis

HYBRIGENICS's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current HYBRIGENICS Net Asset

    
  13.15 M  
Most of HYBRIGENICS's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HYBRIGENICS A is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Based on the recorded statements, HYBRIGENICS A has a Net Asset of 13.15 M. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The net asset for all Germany stocks is notably lower than that of the firm.

HYBRIGENICS Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses HYBRIGENICS's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of HYBRIGENICS could also be used in its relative valuation, which is a method of valuing HYBRIGENICS by comparing valuation metrics of similar companies.
HYBRIGENICS is currently under evaluation in net asset category among its peers.

HYBRIGENICS Fundamentals

About HYBRIGENICS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze HYBRIGENICS A 's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HYBRIGENICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HYBRIGENICS A based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in HYBRIGENICS Stock

HYBRIGENICS financial ratios help investors to determine whether HYBRIGENICS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HYBRIGENICS with respect to the benefits of owning HYBRIGENICS security.